SomnoMed Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Amrita Blickstead

İcra Kurulu Başkanı

AU$624.3k

Toplam tazminat

CEO maaş yüzdesi26.7%
CEO görev süresi4.3yrs
CEO sahipliği0.5%
Yönetim ortalama görev süresi5.3yrs
Yönetim Kurulu ortalama görev süresi4.3yrs

Son yönetim güncellemeleri

Recent updates

Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet

Oct 16
Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet

SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

Jul 15
SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

May 31
SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Apr 15
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Mar 04
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

Dec 21
Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Sep 02
SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Is SomnoMed (ASX:SOM) Using Too Much Debt?

Jun 19
Is SomnoMed (ASX:SOM) Using Too Much Debt?

It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

Nov 18
It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Sep 27
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

May 10
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Oct 26
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

May 12
Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Mar 02
Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Feb 01
Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Dec 28
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Dec 01
Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

Jul 28
Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

Jul 14
SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

CEO Tazminat Analizi

Amrita Blickstead'un ücretlendirmesi SomnoMed'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$624kAU$167k

-AU$12m

Mar 31 2024n/an/a

-AU$11m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$9m

Jun 30 2023AU$91kn/a

-AU$8m

Mar 31 2023n/an/a

-AU$7m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$5m

Jun 30 2022AU$91kn/a

-AU$4m

Mar 31 2022n/an/a

-AU$5m

Dec 31 2021n/an/a

-AU$5m

Sep 30 2021n/an/a

-AU$3m

Jun 30 2021AU$32kn/a

-AU$1m

Tazminat ve Piyasa: Amrita 'nin toplam tazminatı ($USD 414.12K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 304.34K ).

Tazminat ve Kazançlar: Amrita şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Amrita Blickstead

4.3yrs

Görev süresi

AU$624,323

Tazminat

Ms. Amrita Blickstead, MBA, BME, is Co-Chief Executive Officer and Executive Director of SomnoMed Limited. Ms. Blickstead was Non-Executive Director of SomnoMed Limited from August 24, 2020. Ms. Blickstead...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Amrita Blickstead
Co-CEO & Executive Directorno dataAU$624.32k0.49%
A$ 304.2k
Karen Borg
Co-CEO & Executive Directorno dataAU$693.50k0.24%
A$ 146.5k
Mark Harding
Vice President of Global Marketing5.3yrsAU$483.37k0.067%
A$ 41.2k
Matthew Conlon
Executive VP of Sales & Marketing - North America5.1yrsAU$427.31k0%
A$ 0
Marco Van Kleef
Vice President of Marketing & Sales - Europeno dataAU$589.17kVeri yok
Terence Flitcroft
Company Secretary29.8yrsAU$35.38kVeri yok
Christopher Bedford
Vice President of Global Production and Product Developmentno dataAU$128.07kVeri yok

5.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: SOM 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Amrita Blickstead
Co-CEO & Executive Director4.3yrsAU$624.32k0.49%
A$ 304.2k
Karen Borg
Co-CEO & Executive Director4yrsAU$693.50k0.24%
A$ 146.5k
Michael Gordon
Non-Executive Director4.3yrsAU$92.38k0.10%
A$ 64.1k
Iven Klineberg
Member of the Medical Advisory Boardno dataVeri yokVeri yok
J. Gerschman
Member of the Medical Advisory Boardno dataVeri yokVeri yok
Peter Cistulli
Chairman of the Medical Advisory Boardno dataVeri yokVeri yok
Gaetano Russo
Chairman of the Board4.3yrsAU$160.96k0.64%
A$ 396.2k
Benjamin Gisz
Non-Executive Directorless than a yearVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SOM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).